Physician

Carl H Park, M.D.

According to 2025 Medicare claims, Carl Park, M.D. (NPI: 1942274535) practices ophthalmology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from New Castle, DE. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1952552630; TIN: 231932869) and primary practice location at 19713-4181.

Park's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,812 traditional Medicare patients, billed 39,414 HCPCS/CPT codes, and received $5,955,054 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 988 prescription claims across 267 beneficiaries totaling $123,276 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 1 records totaling $92. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.4M$6.7M2015 Medicare payment: $4,972,315 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,420,318 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,677,836 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,657,422 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,700,464 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,993,130 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,432,388 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,880,144 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,612,957 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,955,054 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,01523,870$4,972,315
20162,05824,546$5,420,318
20172,17225,730$5,677,836
20182,41730,120$6,657,422
20192,26729,888$6,700,464
20201,76925,173$5,993,130
20211,83628,031$6,432,388
20221,79127,170$5,880,144
20231,85331,963$5,612,957
20241,81239,414$5,955,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$96K$191K2015 Drug cost: $119,636 (USD; Tot_Drug_Cst)2016 Drug cost: $131,055 (USD; Tot_Drug_Cst)2017 Drug cost: $136,368 (USD; Tot_Drug_Cst)2018 Drug cost: $150,276 (USD; Tot_Drug_Cst)2019 Drug cost: $166,508 (USD; Tot_Drug_Cst)2020 Drug cost: $172,454 (USD; Tot_Drug_Cst)2021 Drug cost: $191,458 (USD; Tot_Drug_Cst)2022 Drug cost: $165,897 (USD; Tot_Drug_Cst)2023 Drug cost: $125,444 (USD; Tot_Drug_Cst)2024 Drug cost: $123,276 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015259948$119,636
2016234866$131,055
2017254861$136,368
2018270928$150,276
20192761,000$166,508
2020224894$172,454
20212471,028$191,458
2022251960$165,897
2023249902$125,444
2024267988$123,276

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3103,768$654
67028Injection of drug into eye6823,326$105
92014Established patient complete exam of visual system796951$94
92012Established patient problem focused exam of visual system9562,553$68
92134Imaging of retina1,6905,044$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium1505,423$27,884
ProlensaBromfenac Sodium602,348$21,093
Prednisolone AcetatePrednisolone Acetate2089,278$8,694
DifluprednateDifluprednate26850$4,682
Diclofenac SodiumDiclofenac Sodium1777,013$1,807

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$92Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carl H. Park, M.D.?

Tedicare shows public-source Medicare data for Carl H. Park, M.D. (NPI 1942274535), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl H. Park, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carl H. Park, M.D.?

Carl H. Park, M.D. is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1952552630) in the available physician profile data.

Does Carl H. Park, M.D. have Open Payments data?

Carl H. Park, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.